The goal of this retrospective study was to assess the diagnostic value and clinical characteristics of painful tonic spasm (PTS) in patients with neuromyelitis optica (NMO). At 2 referral hospitals, ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for neuromyelitis optica (NMO), in a pivotal clinical trial. Just 10% of patients ...

Autoimmune diseases cannot currently be cured, only treated, and this is also true for neuromyelitis optica spectrum disorder, which affects the central nervous system. A Kobe University study of how ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...

"Multi-center randomized controlled trials with large samples will further confirm the association between vitamin D and NMOSD. It may be necessary for doctors to assess the vitamin D levels of ...

Other symptoms in NMOSD occur in CNS areas besides the optic nerve and spinal cord, including intractable nausea, vomiting, and intractable hiccups in area postrema syndrome (APS, a specific brainstem ...

A woman diagnosed with a rare disease in college is now a researcher working to help others navigate their diagnosis through nutrition science.

The agreement is a critical step in ensuring adult patients living with NMOSD and gMG have public access to Ultomiris MISSISSAUGA, ON, Aug. 7, 2025 /CNW/ - Alexion Pharma Canada Corp., AstraZeneca's ...

A curative treatment for NMOSD does not currently exist. The main treatment goals are remission, long-term stabilization of disease course by means of relapse prevention and residual symptom relief.